ADC Therapeutics SA
ADCT
$1.29
-$0.02-1.15%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -96.91M | -136.99M | -142.62M | -166.94M | -169.94M |
| Total Depreciation and Amortization | 235.00K | -110.00K | 235.00K | 915.00K | 1.60M |
| Total Amortization of Deferred Charges | 2.14M | 1.85M | 1.82M | 1.02M | 800.00K |
| Total Other Non-Cash Items | -3.88M | 21.54M | 24.75M | 36.86M | 35.83M |
| Change in Net Operating Assets | -3.86M | -845.00K | -25.36M | -3.75M | 4.40M |
| Cash from Operations | -102.27M | -114.55M | -141.17M | -131.90M | -127.32M |
| Capital Expenditure | -32.00K | -32.00K | -264.00K | -354.00K | -570.00K |
| Sale of Property, Plant, and Equipment | 659.00K | 659.00K | 659.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 627.00K | 627.00K | 395.00K | -354.00K | -570.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 58.68M | 152.59M | 152.66M | 94.35M | 94.35M |
| Repurchase of Common Stock | -2.45M | -2.48M | -1.71M | -1.61M | -2.29M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.00K | -20.00K | -- | -- | -- |
| Cash from Financing | 56.21M | 150.09M | 150.95M | 92.74M | 92.06M |
| Foreign Exchange rate Adjustments | -19.00K | 139.00K | 305.00K | -13.00K | 272.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.45M | 36.31M | 10.47M | -39.53M | -35.56M |